
DBIBB
CAS No. 1569309-92-7
DBIBB( —— )
Catalog No. M33784 CAS No. 1569309-92-7
DBIBB is a non-lipid agonist of specific lysophosphatidic acid (LPA2) type 2 G-protein-coupled receptor.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 53 | Get Quote |
![]() ![]() |
5MG | 81 | Get Quote |
![]() ![]() |
10MG | 129 | Get Quote |
![]() ![]() |
25MG | 255 | Get Quote |
![]() ![]() |
50MG | 365 | Get Quote |
![]() ![]() |
100MG | 525 | Get Quote |
![]() ![]() |
500MG | 1053 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameDBIBB
-
NoteResearch use only, not for human use.
-
Brief DescriptionDBIBB is a non-lipid agonist of specific lysophosphatidic acid (LPA2) type 2 G-protein-coupled receptor.
-
DescriptionDBIBB is a specific nonlipid agonist of the type 2 G protein coupled receptor for lysophosphatidic acid (LPA2). DBIBB mitigates the gastrointestinal radiation syndrome, increases intestinal crypt survival and enterocyte proliferation, and reduces apoptosis. DBIBB represents a agent candidate capable of mitigating acute radiation syndrome caused by high-dose γ-radiation to the hematopoietic and gastrointestinal system.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetLPA Receptor
-
RecptorLPA Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1569309-92-7
-
Formula Weight452.48
-
Molecular FormulaC23H20N2O6S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : ≥ 100 mg/mL (221.00 mM )
-
SMILESOC(=O)c1ccccc1S(=O)(=O)NCCCCN1C(=O)c2cccc3cccc(C1=O)c23
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Patil R, et al. Combined mitigation of the gastrointestinal and hematopoietic acute radiation syndromes by an LPA2 receptor-specific nonlipid agonist. Chem Biol. 2015;22(2):206-216.?
molnova catalog



related products
-
LPA1 receptor antago...
LPA1 receptor antagonist 1(LPA1 R antagonist 1) is a selective and potent lysophosphatidic acid (LPA1) receptor antagonist (IC50 : 25 nM) for the study of idiopathic pulmonary fibrosis.
-
TAK-615
TAK-615 is commonly used to study pulmonary fibrosis and is a negative allosteric modulator of LPA1 receptors.
-
Radioprotectin-1
Radioprotectin-1 is a selective agonist of LPA2 with EC50 of 25 nM for murine LPA2 GPCR and exerts radioprotective and radiomitigative action.